This inventor holds 1 USPTO granted patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Jan DeWeille: Innovator in ASIC1a Channel Blockers
Introduction
Jan DeWeille is a notable inventor based in LeBar s/Loup, France. He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides that inhibit proton-gated sodium channels. His work has implications for various medical applications, especially in the realm of pharmaceuticals.
Latest Patents
Jan DeWeille holds a patent for a polypeptide that functions as an ASIC1a channel blocker. The patent details a substantially pure polypeptide, a nucleic acid coding for this polypeptide, and a method for manufacturing the ASIC1a channel blocker. This invention is crucial for advancing treatments that target specific ion channels in the body.
Career Highlights
DeWeille is affiliated with the Centre National de la Recherche Scientifique, where he conducts his research and development. His work has been instrumental in understanding the mechanisms of ion channels and their role in various physiological processes.
Collaborations
Some of his notable coworkers include Pierre Escoubas and Michel Lazdunski, who have also contributed to the field of ion channel research. Their collaborative efforts have led to advancements in understanding the pharmacological properties of ASIC1a channel blockers.
Conclusion
Jan DeWeille's innovative work in the development of ASIC1a channel blockers highlights his significant role in biochemistry and pharmaceuticals. His contributions continue to pave the way for new therapeutic approaches in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile